Versant Capital Management’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11K Buy
980
+167
+21% +$1.88K ﹤0.01% 1850
2025
Q1
$3.72K Buy
813
+609
+299% +$2.78K ﹤0.01% 2135
2024
Q4
$1.15K Sell
204
-119
-37% -$671 ﹤0.01% 2164
2024
Q3
$1.56K Buy
+323
New +$1.56K ﹤0.01% 1635